Clinical Trial Update: Nepafenac Once Daily for Macular Edema - Study 1 [Phase 3]

View source ↗

Summary

Phase 3 Study 1 evaluated once-daily nepafenac for macular edema in participants with non-proliferative diabetic retinopathy and cataract; results from the comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Diabetic Macular Edema
• Non-proliferative Diabetic Retinopathy

Drugs mentioned

• Nepafenac (nepafenac)

Snippet

Sponsor: Alcon Research | Conditions: Non-Proliferative Diabetic Retinopathy, Cataract | Phase 3 | Status: COMPLETED | Results posted: 2016-08-03